3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase NA
1
Phase 3
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Breast
2
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Conditions
Prostatic Neoplasms
657
Carcinoma, Renal Cell
384
Carcinoma, Non-Small-Cell Lung
242
Urinary Bladder Neoplasms
235
Breast Neoplasms
221
Melanoma
193
Ovarian Neoplasms
191
Neoplasms
178
Colorectal Neoplasms
160
Kidney Neoplasms
152
Neoplasm Metastasis
131
Carcinoma, Transitional Cell
126
Pancreatic Neoplasms
124
Lung Neoplasms
121
Stomach Neoplasms
113
Squamous Cell Carcinoma of Head and Neck
106
Sarcoma
99
Head and Neck Neoplasms
89
Uterine Cervical Neoplasms
87
Carcinoma, Hepatocellular
79
Triple Negative Breast Neoplasms
75
Esophageal Neoplasms
75
Endometrial Neoplasms
74
Colonic Neoplasms
64
Wilms Tumor
56
Small Cell Lung Carcinoma
54
Carcinoma, Ovarian Epithelial
48
Neuroblastoma
47
Liver Neoplasms
46
Testicular Neoplasms
45
Interventions
palbociclib
1
Rivaroxaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Inflammation
×
Genitourinary
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled